Clinical Trials Logo

Clinical Trial Summary

This is a 2-year follow-up study of a cohort of 60 CMT1A patients. The objective is to identify markers allowing to better understand the phenotypic variability observed on patients with CMT1A, to identify predictive markers of the disease's progression and to provide validated measurement tools that can be used as outcome measures in future clinical trials.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02596191
Study type Interventional
Source Assistance Publique Hopitaux De Marseille
Contact Shahram ATTARIAN, MD
Email shahram.attarian@ap-hm.fr
Status Recruiting
Phase N/A
Start date June 6, 2016
Completion date December 6, 2027

See also
  Status Clinical Trial Phase
Recruiting NCT06328712 - Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A Phase 1
Not yet recruiting NCT01289704 - Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A) Phase 2/Phase 3
Completed NCT02967679 - SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study Phase 2
Completed NCT02579759 - Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) Phase 3